Alcon 

€0
210
+€0+0% Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
May 25
€0.24
May 24
€0.24
May 23
€0.21
May 22
€0.19
May 21
€0.09
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
38.79%
1Y Growth
13.83%

Earnings

5MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.69
0.74
0.79
0.84
Expected EPS
0.79736293248
Actual EPS
N/A

Financials

2.79%Profit Margin
Profitable
2018
2019
2020
2021
2022
12.43BRevenue
347.13MNet Income

Analyst Ratings

$69.62Average Price Target
The highest estimate is 75.88.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
63%
Hold
25%
Sell
13%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALC.MI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, competes in the eye health market, particularly in areas like contact lenses and surgical products similar to Alcon's offerings.
Cooper Companies
COO
Mkt Cap13.9B
The Cooper Companies operate through CooperVision and CooperSurgical, offering products that directly compete with Alcon's contact lens and eye care solutions.
Bausch Health Companies
BHC
Mkt Cap2.62B
Bausch Health Companies, through its division Bausch + Lomb, is a direct competitor in the eye health sector, offering a wide range of products from contact lenses to surgical instruments.
Novartis
NVS
Mkt Cap237.61B
Novartis, the former parent company of Alcon, continues to compete in the eye care market through its pharmaceutical products that address conditions like dry eye, retinal issues, and glaucoma.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, through its acquisition of Allergan, competes in the eye care market with products targeting conditions such as dry eye and glaucoma, directly competing with Alcon's portfolio.
Staar Surgical
STAA
Mkt Cap1.28B
STAAR Surgical specializes in ophthalmic products, particularly in implantable lenses for the eye, competing directly with Alcon's intraocular lenses and cataract surgery products.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences, while broader in focus, competes with Alcon in the surgical instruments market, particularly in tools and devices used in ophthalmic surgery.
Eco Science Solutions
ESSI
Mkt Cap26,479
EssilorLuxottica is a leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, competing with Alcon's vision care products.

About

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Show more...
CEO
ISIN
CH0432492467
WKN
000A2PDXE

Listings

0 Comments

Share your thoughts

FAQ

What is Alcon stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Alcon stocks are traded under the ticker ALC.MI.
What is Alcon revenue for the last year?
Alcon revenue for the last year amounts to 12.43B EUR.
What is Alcon net income for the last year?
ALC.MI net income for the last year is 347.13M EUR.
Does Alcon pay dividends?
Yes, ALC.MI dividends are paid annual. The last dividend per share was 0.24 EUR. As of today, Dividend Yield (FWD)% is 0%.
When did Alcon complete a stock split?
Alcon has not had any recent stock splits.